Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Inventory (2016 - 2025)

Rockwell Medical's Inventory history spans 16 years, with the latest figure at $3.4 million for Q4 2025.

  • For Q4 2025, Inventory fell 40.74% year-over-year to $3.4 million; the TTM value through Dec 2025 reached $3.4 million, down 40.74%, while the annual FY2025 figure was $3.4 million, 40.74% down from the prior year.
  • Inventory reached $3.4 million in Q4 2025 per RMTI's latest filing, down from $4.0 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $6.1 million in Q1 2024 to a low of $3.4 million in Q4 2025.
  • Average Inventory over 5 years is $5.1 million, with a median of $5.3 million recorded in 2022.
  • Peak YoY movement for Inventory: surged 42.64% in 2022, then tumbled 40.74% in 2025.
  • A 5-year view of Inventory shows it stood at $4.1 million in 2021, then soared by 42.64% to $5.8 million in 2022, then grew by 0.98% to $5.9 million in 2023, then decreased by 1.58% to $5.8 million in 2024, then tumbled by 40.74% to $3.4 million in 2025.
  • Per Business Quant, the three most recent readings for RMTI's Inventory are $3.4 million (Q4 2025), $4.0 million (Q3 2025), and $4.2 million (Q2 2025).